Semaglutide. Semaglutide is a glucagon-like peptide 1 (GLP-1) analog that acts on appetite centers in the hypothalamus to enhance satiety and reduce food cravings, promoting weight loss in patients with obesity via caloric deficit [93]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.